| 研究実績の概要 |
In this study, the role of VAP-1 in TME was investigated. Intraperitoneal administration of the VAP-1-specific inhibitor U-V296 inhibited murine tumor growth by enhancing IFN-γ-producing tumor antigen-specific CD8+ T cells. U-V296 exhibited significant synergistic anti-tumor effects with ICIs. In the TME of mice treated with U-V296, the expressions of genes associated with immunosuppression were significantly decreased. H2O2, which promoted the production of IL-4 by mouse Th2 and inhibited IFN-γ by mouse Th1 and human tumor-infiltrating lymphocytes, was decreased. These results indicated that VAP-1 is involved in the immunosuppressive TMEs through H2O2-associated Th2/M2 conditions and may be an attractive target for the development of combination cancer immunotherapy with ICIs.
|
